ENDO (Endocan, Corp.) continues to show its strengths,
as our top Marijuana Penny Stock Play.
Finally, after seeing 7 straight days of gains, with consistently green closes, ENDO finally had a little cool down period closing down slightly. Already today, ENDO is again trading to the upside and showing how easily it is able to trend upward on relatively little buying pressure. We are major fans of the manner in which it has been able to consistently move up, on relatively little volume, due to the incredible well-managed share structure. With greater attention, the release of news, and further updates about their relationship with CBIS (Cannabis Science, Inc.) we continue to believe that it will become greatly recognized as one of the strongest marijuana penny stock plays. Over the course of the past month, we have seen more than 4,800% gains on our top winning penny stock picks, with a great deal of this success being due to our impressive marijuana plays. We have seen incredible gains with numerous marijuana plays and believe that although the movement we have seen with END has been significant, there is still a great deal more to come, as this story continues to unfold.
ENDO has remained tight-lipped about developments for quite some time, while it's sister company CBIS has been releasing a steady flow of news developments. Even with the secretive tendencies of ENDO, as of late, leaving investors a bit in the dark, the working relationship with CBIS continues to be of great interest, especially considering the significant price appreciation that CBIS has seen with its stock price as of late. ENDO has managed to continue to mount significant gains without releasing news in over 2 months time, so we believe that there will be significant attention brought its way when they finally do release developments, so be sure to keep a close eye on it.
Pennystockdream.com and its employees are not registered as Investment Adviser's in any jurisdiction whatsoever. We encourage all of those that are interested in any other form of investment, to conduct their own research to garner a better understanding of what they are getting involved in. Be sure to read the full disclaimer for this announcement here: http://www.